Clinical trial
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In…
NCT01458951 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT01458951 |
|---|---|
| Title | A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis |
| Official title | A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis. |
| Acronym | OCTAVE |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | tofacitinib, Placebo |
| Enrollment | 547 |
| Start date | Jun 1, 2012 |
| Primary completion | May 1, 2015 |
| Completion | Jun 1, 2015 |
| First posted | Oct 25, 2011 |
| Last update posted | Jun 1, 2016 |
| Countries | Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czechia, Denmark, Estonia, France, Germany and 17 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: